On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

After taking part in a landmark case against the manufacturers of the synthetic hormone DES, she represented many other ...

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

Hollywood is pulling out the stops this summer movie season, which kicks off with Friday's release Marvel's "Thunderbolts*." ...

Apple reported second-fiscal-quarter earnings Thursday that beat expectations. Amazon reported better-than-expected results ...

Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...

The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on ...

Shares of Eli Lilly fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

The FTSE 100 ended Wednesday 0.37% higher, continuing its longest winning run since late 2016 into early 2017.